Precision Biosciences (DTIL) Preferred Shares (2018 - 2019)
Precision Biosciences' (DTIL) quarterly Preferred Shares came in at $3000.0 in Q1 2019, little changed on a QoQ basis from $3000.0 in Q4 2018.
Precision Biosciences (DTIL) Preferred Shares (2018 - 2019) Analysis & Trends
Precision Biosciences (DTIL) has 2 years of Preferred Shares data on file, last reported at $3000.0 in Q1 2019.
- On a quarterly basis, Preferred Shares changed N/A year-over-year to $3000.0 in Q1 2019; TTM through Mar 2019 was $3000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $3000.0, changed N/A from the prior year.
- Preferred Shares for Q1 2019 stood at $3000.0, roughly flat from $3000.0 in the prior quarter.
- Over the last five years, Preferred Shares for DTIL reached as high as $3000.0 in Q4 2018 and fell as low as $3000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | 3,000.00 |